Home Drug Codes J Codes J9311 · RITUXAN HYCELA
Updated July 1st, 2026

RITUXAN HYCELA J Code: J9311

Injection, rituximab 10 mg and hyaluronidase

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9311, effective October 1, 2026: $36.265 per HCPCS billing unit, down 0.3% from $36.389. From CMS's final file.

?
Medicare Payment Limit ?
$36.389
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$36.389
/ HCPCS billing unit · APC 9467
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, rituximab 10 mg and hyaluronidase
HCPCS Added Date January 1, 2019
Manufacturer Genentech
Route of Administration Subcutaneous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About RITUXAN HYCELA

Rituxan Hycela is a medication aligned to the HCPCS J Code: J9311 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the subcutaneous route and manufactured by Genentech.

According to CMS Drug Use Information: Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). Rituximab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
50242-0108-01 Rituxan Hycela Genentech, Inc. 140 1404 MG / 11.7 ML
50242-0109-01 Rituxan Hycela Genentech, Inc. 160 1608 MG / 13.4 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

RITUXAN HYCELA Pricing & Reimbursement

J9311 Private Payer Reimbursement
$38.06 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

RITUXAN HYCELA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 11.59%
Avg. Days to File 7.2days
Avg. Days to Pay 24.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9311 claims analytics on FocalPoint →
OnPoint Oncology

RITUXAN HYCELA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96401 Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
JW / JZ modifiers apply

CMS has identified Rituxan Hycela (J9311) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

RITUXAN HYCELA Medically Unlikely Edits (MUE)

The most billing units of J9311 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg (rituximab).

Practitioner Office & Hospital Outpatient
160 units / day
= 1,600 mg (rituximab) per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg (rituximab) Enter a dose to see how many billing units it is and whether it is under the limit.

RITUXAN HYCELA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Follicular Lymphoma
Drug Class
CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]Endoglycosidase [EPC]Glycoside Hydrolases [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Rituxan Hycela billing and coding guide?
Billing and coding information for RITUXAN HYCELA can be found through Genentech. Visit Here →
Are there any available Rituxan Hycela patient assistance programs?
RITUXAN HYCELA patient assistance information can be found through Genentech. Visit Here →
Where can I find Rituxan Hycela prescribing information?
RITUXAN HYCELA prescribing information can be found at the link below: Visit Here →
Where can I find Rituxan Hycela side effect information?
Information regarding RITUXAN HYCELA's side effects can be found at MedlinePlus Visit Here →
Does billing RITUXAN HYCELA require JZ/JW wastage modifiers?
CMS has identified RITUXAN HYCELA(J9311) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.